97 related articles for article (PubMed ID: 29776635)
1. Molecular Diagnostics in Esophageal and Gastric Neoplasms: 2018 Update.
Zulfiqar M; Bluth MH; Bhalla A
Clin Lab Med; 2018 Jun; 38(2):357-365. PubMed ID: 29776635
[TBL] [Abstract][Full Text] [Related]
2. Molecular diagnostics in esophageal and gastric neoplasms.
Zulfiqar M; Bhalla A; Weindel M; Shidham VB
Clin Lab Med; 2013 Dec; 33(4):867-73. PubMed ID: 24267191
[TBL] [Abstract][Full Text] [Related]
3. Comparative genomic hybridization of cancer of the gastroesophageal junction: deletion of 14Q31-32.1 discriminates between esophageal (Barrett's) and gastric cardia adenocarcinomas.
van Dekken H; Geelen E; Dinjens WN; Wijnhoven BP; Tilanus HW; Tanke HJ; Rosenberg C
Cancer Res; 1999 Feb; 59(3):748-52. PubMed ID: 9973227
[TBL] [Abstract][Full Text] [Related]
4. Next-generation Sequencing in the Management of Gastric and Esophageal Cancers.
Rubinstein JC; Nicolson NG; Ahuja N
Surg Clin North Am; 2019 Jun; 99(3):511-527. PubMed ID: 31047039
[TBL] [Abstract][Full Text] [Related]
5. [Mutation of p53 gene in human cancers of the esophagus and gastric cardia].
Li HC; Lu SX
Zhonghua Zhong Liu Za Zhi; 1994 May; 16(3):172-6. PubMed ID: 7956692
[TBL] [Abstract][Full Text] [Related]
6. The genetics of gastroesophageal adenocarcinoma and the use of circulating cell free DNA for disease detection and monitoring.
Openshaw MR; Richards CJ; Guttery DS; Shaw JA; Thomas AL
Expert Rev Mol Diagn; 2017 May; 17(5):459-470. PubMed ID: 28306358
[TBL] [Abstract][Full Text] [Related]
7. Association of adenocarcinomas of the distal esophagus, "gastroesophageal junction," and "gastric cardia" with gastric pathology.
Wijetunge S; Ma Y; DeMeester S; Hagen J; DeMeester T; Chandrasoma P
Am J Surg Pathol; 2010 Oct; 34(10):1521-7. PubMed ID: 20871225
[TBL] [Abstract][Full Text] [Related]
8. Gene methylation in gastric cancer.
Qu Y; Dang S; Hou P
Clin Chim Acta; 2013 Sep; 424():53-65. PubMed ID: 23669186
[TBL] [Abstract][Full Text] [Related]
9. What Will We Expect From Novel Therapies to Esophageal and Gastric Malignancies?
De Mello RA; Castelo-Branco L; Castelo-Branco P; Pozza DH; Vermeulen L; Palacio S; Salzberg M; Lockhart AC
Am Soc Clin Oncol Educ Book; 2018 May; 38():249-261. PubMed ID: 30231398
[TBL] [Abstract][Full Text] [Related]
10. Accumulation of somatic mutations in TP53 in gastric epithelium with Helicobacter pylori infection.
Shimizu T; Marusawa H; Matsumoto Y; Inuzuka T; Ikeda A; Fujii Y; Minamiguchi S; Miyamoto S; Kou T; Sakai Y; Crabtree JE; Chiba T
Gastroenterology; 2014 Aug; 147(2):407-17.e3. PubMed ID: 24786892
[TBL] [Abstract][Full Text] [Related]
11. Early diagnosis and management of esophageal and gastric cancer.
Lang GD; Konda VJ
Minerva Gastroenterol Dietol; 2013 Dec; 59(4):357-76. PubMed ID: 24212354
[TBL] [Abstract][Full Text] [Related]
12. Clinicopathologic features and treatment outcomes of patients with human epidermal growth factor receptor 2-positive adenocarcinoma of the esophagus and gastroesophageal junction.
Phillips BE; Tubbs RR; Rice TW; Rybicki LA; Plesec T; Rodriguez CP; Videtic GM; Saxton JP; Ives DI; Adelstein DJ
Dis Esophagus; 2013 Apr; 26(3):299-304. PubMed ID: 22676551
[TBL] [Abstract][Full Text] [Related]
13. Alterations of the CCND1 and HER-2/neu (ERBB2) proteins in esophageal and gastric cancers.
Bizari L; Borim AA; Leite KR; Gonçalves Fde T; Cury PM; Tajara EH; Silva AE
Cancer Genet Cytogenet; 2006 Feb; 165(1):41-50. PubMed ID: 16490596
[TBL] [Abstract][Full Text] [Related]
14. Associations of alcohol use disorders with esophageal and gastric cancers: a population-based study in Sweden.
Ji J; Sundquist J; Sundquist K
Eur J Cancer Prev; 2017 Mar; 26(2):119-124. PubMed ID: 26886238
[TBL] [Abstract][Full Text] [Related]
15. Epidemiology of adenocarcinoma of the esophagus, gastric cardia, and upper gastric third.
Vial M; Grande L; Pera M
Recent Results Cancer Res; 2010; 182():1-17. PubMed ID: 20676867
[TBL] [Abstract][Full Text] [Related]
16. The prevalence of Helicobacter pylori infection and the status of gastric acid secretion in patients with gastroesophageal junction adenocarcinoma in Japan.
Koike T; Ohara S; Inomata Y; Abe Y; Iijima K; Shimosegawa T
Inflammopharmacology; 2007 Apr; 15(2):61-4. PubMed ID: 17450443
[TBL] [Abstract][Full Text] [Related]
17. HER2 testing in gastric and gastroesophageal junction cancers: a new therapeutic target and diagnostic challenge.
Hicks DG; Whitney-Miller C
Appl Immunohistochem Mol Morphol; 2011 Dec; 19(6):506-8. PubMed ID: 22089490
[TBL] [Abstract][Full Text] [Related]
18. Preservation of gastric acid secretion may be important for the development of gastroesophageal junction adenocarcinoma in Japanese people, irrespective of the H. pylori infection status.
Inomata Y; Koike T; Ohara S; Abe Y; Sekine H; Iijima K; Ariizumi K; Yamagishi H; Kitagawa Y; Imatani A; Shimosegawa T
Am J Gastroenterol; 2006 May; 101(5):926-33. PubMed ID: 16573782
[TBL] [Abstract][Full Text] [Related]
19. Loss of heterozygosity and immunohistochemistry of adenocarcinomas of the esophagus and gastric cardia.
Marsman WA; Birjmohun RS; van Rees BP; Caspers E; Johan G; Offerhaus A; Bosma PJ; Jan J; van Lanschot B
Clin Cancer Res; 2004 Dec; 10(24):8479-85. PubMed ID: 15623628
[TBL] [Abstract][Full Text] [Related]
20. High frequency of simultaneous loss of p16 and p16beta gene expression in squamous cell carcinoma of the esophagus but not in adenocarcinoma of the esophagus or stomach.
Hayashi K; Metzger R; Salonga D; Danenberg K; Leichman LP; Fink U; Sendler A; Kelsen D; Schwartz GK; Groshen S; Lenz HJ; Danenberg PV
Oncogene; 1997 Sep; 15(12):1481-8. PubMed ID: 9333024
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
